Evidence map›Paper›PMID 32740810›Full record

ArticleClinical oral investigations2021

Adipokines and periodontal markers as risk indicators of early rheumatoid arthritis: a cross-sectional study.

Jacqueline Rodríguez, Gloria Inés Lafaurie, Wilson Bautista-Molano, Lorena Chila-Moreno, Juan Manuel Bello-Gualtero, Consuelo Romero-Sánchez

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Breast Cancer and Microcalcifications: An Osteoimmunological Disorder?International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jacqueline RodríguezSchool of Dentistry, Unit of Basic Oral Investigation-UIBO, Universidad El Bosque, Universidad El Bosque Av. Cra. 9 #131A-02, Bogotá, Colombia.
Gloria Inés LafaurieSchool of Dentistry, Unit of Basic Oral Investigation-UIBO, Universidad El Bosque, Universidad El Bosque Av. Cra. 9 #131A-02, Bogotá, Colombia.
Wilson Bautista-MolanoSchool of Dentistry, Cellular and Molecular Immunology Group/INMUBO, Universidad El Bosque, Universidad El Bosque Av. Cra. 9 #131A-02, Bogotá, Colombia.
Lorena Chila-MorenoSchool of Dentistry, Cellular and Molecular Immunology Group/INMUBO, Universidad El Bosque, Universidad El Bosque Av. Cra. 9 #131A-02, Bogotá, Colombia.
Juan Manuel Bello-GualteroHospital Militar Central, Rheumatology and Immunology Department, School of Medicine, Universidad Militar Nueva Granada, Clinical Immunology Group, Transversal 3ª #49-00, Bogotá, Colombia.
Consuelo Romero-SánchezSchool of Dentistry, Cellular and Molecular Immunology Group/INMUBO, Universidad El Bosque, Universidad El Bosque Av. Cra. 9 #131A-02, Bogotá, Colombia. romeromaria@unbosque.edu.co.ORCID http://orcid.org/0000-0002-6973-7639
Universidad El Bosque · COMilitary University Nueva Granada · CO

Funding

Administrative Department of Science, Technology, and Innovation-COLCIENCIAS Grant No. 130865740792-2014Hospital Militar Central Grant 2016-099
6 · The paper itself

Abstract

objectiveTo establish the association between adipokine levels and markers of periodontal involvement as risk indicators of early stages of RA (eRA) and the interaction between the presence of markers of periodontal disease with adipokine in eRA individuals. MATERIALS AND

methodsFifty-one patients with a diagnosis of eRA and 51 healthy controls matched for age and sex were studied. Clinical joint condition, clinical and serological markers of disease activity, serum adipokine levels (leptin, adiponectin, resistin, adipsin, vaspin, and IL-6), periodontal diagnosis, presence of Porphyromonas gingivalis, and related IgG1 and IgG2 antibodies were evaluated. Comparisons were made between eRA and healthy controls for periodontal indicators and adipokines. A subgroup analysis was realized with a non-conditional logistic regression to establish the association between the levels of leptin in individuals with eRA and controls according to the periodontal condition, presence of P. gingivalis, or high titers of IgG antibodies against P. gingivalis.

resultsThe condition of overweight or obesity is associated with the diagnosis of eRA (p = 0.05), and these individuals also have higher levels of leptin (p = 0.001) and vaspin (p = 0.007). Higher frequency of P. gingivalis (p = 0.001) was found in the eRa group. Individuals with eRA with higher IgG2 titers against P. gingivalis had higher levels of leptin (OR: 1.66 (CI 95% 1.01-2.73)); however, individuals with periodontitis or P. gingivalis with eRA were associated with highest levels of leptin (OR: 1.86, CI 95% 1.19-24.3; and OR: 2.04, CI 95% 1.37-3 respectively).

conclusionseRA individuals have high levels of leptin and vaspin. However, the presence of periodontitis and related-periodontal disease markers showed an effect only in leptin levels in eRA individuals. CLINICAL RELEVANCE: Emphasizing in personalized medicine, monitoring serum leptin levels and periodontitis markers can improve the early diagnosis of RA.

Indexed as

Arthritis, RheumatoidPeriodontitisAdipokinesCross-Sectional StudiesHumansPorphyromonas gingivalisAdipokinesAdipokinesArthritisObesityPeriodontitisPorphyromonas gingivalisRheumatoid

Identifiers

PMID32740810
OpenAlexW3046594577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.